These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35767638)

  • 21. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
    Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
    J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK; Tan FU; Kendi T; Koc C
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
    Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
    J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ; Yum KW; Lee SS; Heo MS; Seo K
    Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical masseteric bulging after botulinum neurotoxin type A injection.
    Sandhu S; Shaefer J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
    Nikolis A; Enright KM; Rudolph C; Cotofana S
    J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Hwang K
    Dermatol Surg; 2014 Dec; 40(12):1340-1. PubMed ID: 25380090
    [No Abstract]   [Full Text] [Related]  

  • 30. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary on a Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Cox SE
    Dermatol Surg; 2015 Nov; 41(11):1309. PubMed ID: 26448313
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY; Kim ST
    Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Bae JH; Choi DY; Lee JG; Seo KK; Tansatit T; Kim HJ
    Dermatol Surg; 2014 Dec; 40(12):1334-9. PubMed ID: 25393348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pivotal role of injection volume on sunken cheek prevention in masseter muscle BoNT-A injection: A cadaver study.
    Yu P; Zhai H; Li Z; Dong R; Wu T; Li Y; Di Z; Sun Y; Long X; Yu N
    J Cosmet Dermatol; 2022 Jan; 21(1):137-141. PubMed ID: 34897934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Masseter Muscle Volume Changes Evaluated by 3-Dimensional Computed Tomography After Repeated Botulinum Toxin A Injections in Patients With Square Facial Morphology.
    Chang CS; Lin S; Wallace CG; Hsiao YC; Lin CM; Kang GC; Chen ZC; Chen PK; Lo LJ; Chen YR; Chen JP
    Ann Plast Surg; 2019 Jan; 82(1S Suppl 1):S29-S32. PubMed ID: 30540604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.